Categories: AnalystsSoftware

Solium Capital is undervalued, says Euro Pacific analyst Andrej Krneta

The market is mispricing Solium Capital’s (TSX:SUM) potential, says Euro Pacific Canada analyst Andrej Krneta.

Today, after market, Solium will report its fourth quarter and fiscal 2014 results. Krneta expects that the company’s fourth quarter revenue will grow 10.7% year-over-year to $19.2-million, slightly lower than street consensus of $19.6-million. He thinks Solium will remain at the high end of its own EBITDA target of 20-25%.

The analyst says he is looking for clarity on the company’s international expansion plans.

“We expect organic growth in Canada with the US subdued due to the ever-present competitive pressures,” he said. “The rollout in the UK remains ongoing, but a surge in seats served through its white-labelling is unlikely. Thus, much of the focus should stay outside of North America”.

Krneta says that with uptake slower than expected in the UK, the Australian market remains a viable option for the company.

In a research update to clients yesterday, Krneta maintained his “Buy” rating and one-year target of $9.50 on Solium Capital, implying a return of 19% at the time of publication. He says further upside could come from a “more aggressive approach to capital allocations”, and thinks the current valuation is mispricing the company’s growth potential.

At press time, shares of Solium Capital were down 2% to $6.77.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: sum
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Should you buy AMZN? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Amazon (Amazon Stock… [Read More]

18 mins ago

These cannabis stocks will benefit most from reclassification

It happened. The move that everyone in the cannabis sector was hoping for came about swiftly on the last day… [Read More]

7 hours ago

Is AMD stock a buy? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Suji Desilva has maintained his "Buy" rating on Advanced Micro Devices… [Read More]

8 hours ago

Is Wolfspeed stock still a buy?

Ahead of the company's third quarter results, Roth MKM analyst Scott Irwin has maintained his "Buy" rating on Wolfspeed (Wolfspeed… [Read More]

9 hours ago

WELL Health inks five-year deal with Microsoft

It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]

1 day ago

Is Thomson Reuters stock a buy right now?

Its stock has made a since last October, but is there more upside left in Thomson Reuters (Thomson Reuters Stock… [Read More]

1 day ago